Dezhan Healthcare Company Limited (SZSE: 000813)
Health Care · Pharmaceuticals · CN
CN¥3.23
+0.94% today · -25.4% 1Y
Dezhan Healthcare Company Limited (SZSE: 000813) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.01B and employs 1,195 people.
Over the last twelve months the share price has lost 25.4%, trading between 2.75 and 4.73.
Tweenvest scores Dezhan Healthcare Company Limited across four factors: quality 66/100, value 52/100, growth 0/100. Its strongest factor is quality.
000813 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.01B
- Revenue (TTM)
- $54.92M
- P/E
- —
- EPS
- -0.17
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- CN¥4.73
- 52-week low
- CN¥2.75
- Avg volume (3M)
- —
- Shares outstanding
- 2.10B
- Employees
- 1,195
- Next earnings
- —
About Dezhan Healthcare Company Limited
Dezhan Healthcare Company Limited operates primarily within the Chinese market, specializing in the research, development, manufacturing, and distribution of pharmaceutical products, with a particular focus on cardiovascular and cerebrovascular medications. The company's product range also extends to include oncology drugs, a variety of health and wellness products, functional beverages, and ecological water. Established in 1998, the firm maintains its headquarters in Urumqi, China.
- ISIN
- CNE000000VV8
- Founded
- 1980
- Listed since
- May 19, 1998
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Animal Husbandry Industry Co., Ltd.SHSE: 600195 | $1.02B | CN¥6.73 | +1.36% |
| Zhejiang Ausun Pharmaceutical Co., Ltd.SHSE: 603229 | $1.02B | CN¥8.26 | +1.35% |
| Northeast Pharmaceutical Group Co., Ltd.SZSE: 000597 | $1.01B | CN¥4.76 | +1.06% |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.SEHK: 1349 | $1.01B | HK$2.53 | -3.07% |
| SSY Group LimitedSEHK: 2005 | $1.01B | HK$2.74 | -0.54% |
| Pacira BioSciences, Inc.NasdaqGS: PCRX | $1.00B | $25.20 | +1.78% |
| Hunan Er-Kang Pharmaceutical Co., LtdSZSE: 300267 | $1.00B | CN¥3.26 | +2.19% |
| Vetoquinol SAENXTPA: VETO | $995.06M | €76.10 | -0.52% |
Figures last refreshed Oct 4, 2026.